Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

COVID-19 vaccination may trigger lupus in some people.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Topical corticosteroids are effective for skin conditions but can have side effects.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

RTA 408 cream protects mice from radiation skin damage.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

34% of patients on hepatitis C treatment had reversible skin issues.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Apremilast improved symptoms in patients with severe skin conditions.

Vemurafenib can cause scalp issues but can be managed without changing the dose.